Merck & Co., Inc. (MRK) takes the lead with a stronger overall profile.
AbbVie Inc. (ABBV) and Merck & Co., Inc. (MRK) are two of the most popular dividend stocks that investors frequently compare. Both offer regular dividend income, but they differ in yield, growth trajectory, and overall quality. This analysis compares them head-to-head across income, quality, and valuation metrics using FluentBoost’s dividend analysis methodology.
💰 Income & Yield
| Metric | ABBV | MRK | Advantage |
|---|---|---|---|
| Dividend Yield | 3.31% | 2.94% | ABBV |
| Annual Dividend | $6.92 | $3.40 | — |
| Income per $10k | $331 | $294 | ABBV |
| Yield vs 5Y Avg | 3.31% vs 4.46% | 2.94% vs 2.60% | MRK |
| Yield Zone | HOLD | HOLD | — |
✅ Quality & Reliability
| Metric | ABBV | MRK | Advantage |
|---|---|---|---|
| Quality Rating | C+ | C+ | Draw |
| Consecutive Div Years | 14 years | 65 years | MRK |
| Div Increases (12Y) | 11/12 | 11/12 | Draw |
| EPS Increases (12Y) | 6/12 | 7/12 | MRK |
| Institutional Holders | 764 | 813 | MRK |
| Dividend Cuts (12Y) | 0 | 0 | Draw |
📈 Valuation
| Metric | ABBV | MRK | Advantage |
|---|---|---|---|
| P/E Ratio | 88.6x | 15.8x | MRK |
| EV/EBITDA | 14.8x | 11.0x | MRK |
| Price-to-Book | -113.0x | 5.4x | ABBV |
| Price-to-FCF | 20.2x | 24.0x | ABBV |
Overall Scorecard
Dividend Analysis
ABBV offers a dividend yield of 3.31% with 14 consecutive years of dividends and 11 increases in the past 12 years. It has had no dividend cuts in that period.
MRK yields 2.94% with 65 consecutive years of dividends and 11 increases in the past 12 years. It has had no dividend cuts in that period.
For pure income seekers, ABBV currently provides the higher yield. For dividend growth, Tie — both are equally matched.
Final Verdict
Based on our comprehensive analysis, MRK wins this comparison with 6 advantages versus 4 for ABBV (with 3 draws).
Want to Compare Your Own Stocks?
Use the FluentBoost Analyzer to get instant dividend analysis, yield zone ratings, and quality scores on any stock.
This comparison is for informational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research before making investment decisions.
Report generated on April 17, 2026 by FluentBoost — fluentboost.com
Related Articles
